PT1165791E - Citocina humana como ligando do receptor zalpha e seus usos - Google Patents

Citocina humana como ligando do receptor zalpha e seus usos Download PDF

Info

Publication number
PT1165791E
PT1165791E PT00916164T PT00916164T PT1165791E PT 1165791 E PT1165791 E PT 1165791E PT 00916164 T PT00916164 T PT 00916164T PT 00916164 T PT00916164 T PT 00916164T PT 1165791 E PT1165791 E PT 1165791E
Authority
PT
Portugal
Prior art keywords
ligand
polypeptide
human cytokine
zalpha
receptor
Prior art date
Application number
PT00916164T
Other languages
English (en)
Inventor
Richard D Holly
Donald C Foster
Julie E Novak
Scott R Presnell
Cindy A Sprecher
Jane A Gross
Janet V Johnston
Andrew J Nelson
Stacey R Dillon
Angela K Hammond
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1165791(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of PT1165791E publication Critical patent/PT1165791E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00916164T 1999-03-09 2000-03-09 Citocina humana como ligando do receptor zalpha e seus usos PT1165791E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26490899A 1999-03-09 1999-03-09
US26599299A 1999-03-11 1999-03-11
US14201399P 1999-07-01 1999-07-01

Publications (1)

Publication Number Publication Date
PT1165791E true PT1165791E (pt) 2008-01-16

Family

ID=27385745

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00916164T PT1165791E (pt) 1999-03-09 2000-03-09 Citocina humana como ligando do receptor zalpha e seus usos

Country Status (23)

Country Link
EP (3) EP1881070B1 (pt)
JP (1) JP4405686B2 (pt)
KR (1) KR100743640B1 (pt)
CN (5) CN102406937A (pt)
AT (1) ATE377076T1 (pt)
AU (2) AU777842B2 (pt)
BR (1) BR0008772B1 (pt)
CA (1) CA2366921C (pt)
CZ (1) CZ302921B6 (pt)
DE (1) DE60036930T2 (pt)
DK (1) DK1165791T3 (pt)
ES (1) ES2295019T3 (pt)
HU (1) HU229148B1 (pt)
IL (5) IL145288A0 (pt)
MX (1) MXPA01009074A (pt)
NO (2) NO331551B1 (pt)
NZ (1) NZ514708A (pt)
PL (1) PL207350B1 (pt)
PT (1) PT1165791E (pt)
RU (1) RU2346951C2 (pt)
UA (1) UA84387C2 (pt)
WO (1) WO2000053761A2 (pt)
ZA (1) ZA017370B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
RU2346951C2 (ru) * 1999-03-09 2009-02-20 Займодженетикс, Инк. Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты)
ES2629395T3 (es) * 2001-10-04 2017-08-09 Genetics Institute, Llc Métodos y composiciones para modular la actividad de la interleucina-21
MXPA04004167A (es) 2001-11-05 2004-07-08 Zymogenetics Inc Antagonistas de interleucina-21.
MXPA04012116A (es) * 2002-06-07 2005-04-19 Zymogenetics Inc Uso del il-21 en cancer y otras aplicaciones terapeuticas.
BR0312738A (pt) 2002-07-15 2007-06-26 Wyeth Corp processos e composições para a modulação do desenvolvimento e da função de células t auxiliares (th)
US20060177421A1 (en) * 2002-10-11 2006-08-10 Novo Nordisk A/S Treatment of allergic conditions by use of il 21
CA2501807A1 (en) * 2002-10-11 2004-04-22 Novo Nordisk A/S Treatment of allergic conditions by use of il 21
JP4664684B2 (ja) * 2002-12-13 2011-04-06 ザイモジェネティクス， インコーポレイテッド 原核生物宿主におけるｉｌ−２１の生産
RU2005131852A (ru) 2003-03-14 2006-04-20 Уайт (Us) Антитела против человеческого рецептора il-21 и их применение
CA2529520A1 (en) * 2003-06-19 2004-12-29 Centocor, Inc. Interleukin-21 analogs
WO2005014642A2 (en) 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
WO2005030196A2 (en) * 2003-09-25 2005-04-07 Zymogenetics, Inc. Methods of treating autoimmune diseases using il-21
JP2007533298A (ja) * 2003-10-10 2007-11-22 ノボ　ノルディスク　アクティーゼルスカブ Ｉｌ−２１の誘導体
US20060228331A1 (en) * 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
EP2633866A3 (en) 2003-10-17 2013-12-18 Novo Nordisk A/S Combination therapy
JP2007522109A (ja) * 2004-01-15 2007-08-09 ノボ　ノルディスク　アクティーゼルスカブ 自己免疫疾患の治療およびｉｌ−２１での同種異系移植片拒絶反応
CN1909930B (zh) 2004-01-21 2015-12-16 诺和诺德医疗保健公司 转谷氨酰胺酶介导的肽的接合
GT200600148A (es) 2005-04-14 2006-11-22 Metodos para el tratamiento y la prevencion de fibrosis
KR20080013878A (ko) 2005-04-18 2008-02-13 노보 노르디스크 에이/에스 Ｉｌ-21 변이체
ES2491118T3 (es) * 2005-11-28 2014-09-05 Zymogenetics, Inc. Antagonistas de IL-21
EP2091968A2 (en) 2006-10-26 2009-08-26 Novo Nordisk A/S Il-21 variants
CA2671665A1 (en) 2006-12-21 2008-06-26 Novo-Nordisk A/S Interleukin-21 variants with altered binding to the il-21 receptor
KR101591316B1 (ko) 2007-12-07 2016-02-05 지모제넥틱스, 인코포레이티드 항-사람 ｉｌ-21 단클론성 항체
AR071885A1 (es) 2008-05-23 2010-07-21 Wyeth Corp Proteinas de union al receptor de interleuquina 21
RU2010152689A (ru) 2008-05-23 2012-06-27 УАЙТ ЭлЭлСи (US) Способы лечения с применением белков, связывающих рецептор интерлейкина-21
CA2739357A1 (en) 2008-09-23 2010-04-08 Wyeth Llc Methods for predicting production of activating signals by cross-linked binding proteins
CN102021196B (zh) * 2009-11-20 2013-06-26 上海杰隆生物工程股份有限公司 毕赤酵母生产重组人白细胞介素21的方法
JP6464081B2 (ja) 2012-06-27 2019-02-06 ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー フローサイトメトリーを用いたｒｎａ測定によるｔ細胞活性化のための迅速アッセイ
WO2015110930A1 (en) 2014-01-24 2015-07-30 Pfizer Inc. Modified interleukin 21 receptor proteins
EP2982693A1 (en) * 2014-08-07 2016-02-10 Affimed Therapeutics AG CD3 binding domain
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
CN112662694A (zh) * 2020-12-25 2021-04-16 康九生物科技(长春)有限公司 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560472B2 (en) 1981-08-25 1987-04-09 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0184576B1 (en) 1984-12-06 1990-06-27 Fina Research S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
EP1762623A1 (en) 1988-01-22 2007-03-14 ZymoGenetics, Inc. Methods for producing biologically active peptide dimers
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
EP0749319A1 (en) 1992-09-14 1996-12-27 Pfizer Inc. Immortalized cells and uses therefor
JPH09501055A (ja) 1993-07-30 1997-02-04 ユニバーシティ オブ メディシン アンド デンティストリー オブ ニュージャージー 初代リンパ球への効率的遺伝子転移
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
US5965389A (en) 1995-11-09 1999-10-12 Zymogenetics, Inc. Production of GAD65 in methylotrophic yeast
IL128073A0 (en) 1996-07-17 1999-11-30 Zymogenetics Inc Transformation of pichia methanolica
WO1998002536A2 (en) 1996-07-17 1998-01-22 Zymogenetics, Inc. Preparation of pichia methanolica auxotrophic mutants
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US6057128A (en) * 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
RU2346951C2 (ru) * 1999-03-09 2009-02-20 Займодженетикс, Инк. Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты)
US9418201B1 (en) 2015-11-19 2016-08-16 International Business Machines Corporation Integration of functional analysis and common path pessimism removal in static timing analysis

Also Published As

Publication number Publication date
PL207350B1 (pl) 2010-12-31
IL207403A (en) 2012-03-29
BR0008772B1 (pt) 2011-11-01
HUP0200418A2 (hu) 2002-05-29
UA84387C2 (ru) 2008-10-27
EP2295577A2 (en) 2011-03-16
RU2004126135A (ru) 2006-02-10
MXPA01009074A (es) 2002-03-27
CA2366921A1 (en) 2000-09-14
NO20014364L (no) 2001-11-09
NO20111085L (no) 2001-11-09
EP1881070A2 (en) 2008-01-23
JP4405686B2 (ja) 2010-01-27
AU777842B2 (en) 2004-11-04
BR0008772A (pt) 2002-05-07
EP1881070B1 (en) 2012-10-03
CN101575377B (zh) 2012-12-26
DE60036930D1 (de) 2007-12-13
NZ514708A (en) 2005-01-28
HU229148B1 (en) 2013-09-30
CN1827639A (zh) 2006-09-06
CN100500846C (zh) 2009-06-17
IL145288A (en) 2010-11-30
AU2005200240A1 (en) 2005-02-17
CZ20013184A3 (cs) 2002-04-17
CN1378595A (zh) 2002-11-06
EP2295577A3 (en) 2012-08-08
PL351160A1 (en) 2003-03-24
KR20010103794A (ko) 2001-11-23
RU2346951C2 (ru) 2009-02-20
CN1927883A (zh) 2007-03-14
DE60036930T2 (de) 2008-10-09
EP1881070A3 (en) 2008-03-05
HUP0200418A3 (en) 2003-12-29
JP2002537839A (ja) 2002-11-12
EP1165791A2 (en) 2002-01-02
IL195713A (en) 2010-11-30
CZ302921B6 (cs) 2012-01-18
ATE377076T1 (de) 2007-11-15
EP1165791B1 (en) 2007-10-31
IL207424A (en) 2013-04-30
AU3731200A (en) 2000-09-28
NO20014364D0 (no) 2001-09-07
CN1927883B (zh) 2011-09-21
IL145288A0 (en) 2002-06-30
ES2295019T3 (es) 2008-04-16
CN101575377A (zh) 2009-11-11
CA2366921C (en) 2013-12-17
KR100743640B1 (ko) 2007-07-27
NO331551B1 (no) 2012-01-23
WO2000053761A2 (en) 2000-09-14
WO2000053761A3 (en) 2000-12-21
CN102406937A (zh) 2012-04-11
DK1165791T3 (da) 2008-02-11
ZA017370B (en) 2002-06-26

Similar Documents

Publication Publication Date Title
PT1165791E (pt) Citocina humana como ligando do receptor zalpha e seus usos
MX9702212A (es) Proteinas plaguicidas novedosas y cepas.
ZA943465B (en) Transforming growth factor alpha H1
MX9804419A (es) Receptor polipeptidico de il-i3.
EP2258383A3 (en) Antigenic peptides derived from telomerase
HK1078093A1 (en) Antibodies against fibroblast growth factor 23
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
AU9574198A (en) Method of affinity cross-linking biologically active, immunogenic peptides to antibodies
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
EP0967283A4 (en) GENES CODING FOR PROTEINS WITH TRANSGLYCOLYSTING ACTIVITY.
AU2002307510A1 (en) Cytokine protein family
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
AU2043597A (en) Human taki dna encoding the same
AUPP031897A0 (en) Mammalian milk growth factor
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
EP1295943A4 (en) POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES
EP1092773A3 (en) Polypeptide and uses thereof
NZ536318A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
NZ606260A (en) Novel polypeptides involved in immune response
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
EP1029914A3 (en) Growth hormone-regulated growth marker gene
WO2000070015A3 (fr) Cultures de cellules d'insecte se multipliant a 37°c, leur p rocede d'obtention, et leurs utilisations